Hilltop National Bank Decreases Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Hilltop National Bank trimmed its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 10.3% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 383 shares of the company’s stock after selling 44 shares during the period. Hilltop National Bank’s holdings in HCA Healthcare were worth $115,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently bought and sold shares of the business. FMR LLC lifted its holdings in HCA Healthcare by 322.3% during the 3rd quarter. FMR LLC now owns 3,141,769 shares of the company’s stock worth $1,276,909,000 after buying an additional 2,397,883 shares during the last quarter. Franklin Resources Inc. increased its position in shares of HCA Healthcare by 11.7% during the third quarter. Franklin Resources Inc. now owns 1,669,721 shares of the company’s stock worth $660,842,000 after purchasing an additional 174,946 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in shares of HCA Healthcare by 2.8% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,487,367 shares of the company’s stock worth $604,511,000 after purchasing an additional 41,190 shares in the last quarter. Janus Henderson Group PLC increased its position in shares of HCA Healthcare by 12.0% during the third quarter. Janus Henderson Group PLC now owns 1,339,638 shares of the company’s stock worth $544,467,000 after purchasing an additional 143,995 shares in the last quarter. Finally, Darsana Capital Partners LP increased its position in shares of HCA Healthcare by 53.3% during the second quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock worth $369,472,000 after purchasing an additional 400,000 shares in the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $303.64 on Friday. The business’s 50 day simple moving average is $321.66 and its 200-day simple moving average is $353.61. The firm has a market capitalization of $76.91 billion, a price-to-earnings ratio of 13.63, a price-to-earnings-growth ratio of 1.21 and a beta of 1.64. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. HCA Healthcare, Inc. has a 12 month low of $276.50 and a 12 month high of $417.14.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, December 27th. Investors of record on Friday, December 13th were paid a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a yield of 0.87%. The ex-dividend date of this dividend was Friday, December 13th. HCA Healthcare’s payout ratio is currently 11.85%.

Wall Street Analyst Weigh In

A number of analysts have recently commented on HCA shares. KeyCorp cut their target price on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research report on Tuesday. StockNews.com cut HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. TD Cowen dropped their price target on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research report on Monday, October 28th. Raymond James cut HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday, November 22nd. Finally, Oppenheimer lifted their price objective on HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a report on Monday, October 28th. One research analyst has rated the stock with a sell rating, three have given a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $385.27.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the transaction, the senior vice president now directly owns 52,702 shares in the company, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Erol R. Akdamar sold 2,900 shares of the business’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the transaction, the insider now owns 6,843 shares of the company’s stock, valued at $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.70% of the stock is owned by corporate insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.